Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States

Genetics in Medicine(2022)10.1016/j.gim.2022.10.012Source: DataRank Database

Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States is a research paper published in Genetics in Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

omim

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.54)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Wendy K. K. Lam ORCID,Scott D. Grosse ORCID,Jelili Ojodu,Elizabeth Jones ORCID,Lisa A. Prosser

Live enrichment

PubMed:36445366 PMC:PMC9905270 OpenAlex:https://openalex.org/W4310460607

U.S. Department of Health and Human Services

Grant: 75R60220R00023

Intramural CDC HHS

Grant: CC999999

Association of Public Health Laboratories

Centers for Disease Control and Prevention

Health Resources and Services Administration

FWCI

1.54

Citation Percentile

0.8%

Influential Citations

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9905270

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905270

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9905270

publisherhttps://api.elsevier.com/content/article/PII:S1098360022009984?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1098360022009984?httpAccept=text/plain

Fields of Study

Lysosomal Storage Disorders ResearchTrypanosoma species research and implicationsGlycogen Storage Diseases and MyoclonusMedicineChildHumansInfant, NewbornUnited StatesMucopolysaccharidosis IINeonatal ScreeningIduronic AcidIduronate SulfataseGlycosaminoglycansEnzyme Replacement Therapy

MeSH Terms

ChildGlycosaminoglycansHumansIduronate SulfataseIduronic AcidInfant, NewbornUnited StatesNeonatal ScreeningMucopolysaccharidosis IIEnzyme Replacement Therapy

Keywords

Mucopolysaccharidosis type IIHunter syndromeNewborn screeningMedicineEnzyme replacement therapyAdvisory committeeMucopolysaccharidosisFood and drug administrationPediatricsMucopolysaccharidosis type IDiseaseInternal medicinePharmacologyEvidence ReviewAchdnc

Sustainable Development Goals

SDG 0: Good health and well-being

Evidence and recommendation for mucopolysaccharidosis type II newborn screening in the United States

FAIR Checklist

Authors (11)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)